Ischemia-reperfusion Injury Clinical Trial
Official title:
Ischemia-reperfusion Injury Model on Healthy Volunteers and Measurement of Oxidative and Inflammatory Markers
Oxygen is necessary for the survival of oxygen consuming organisms. But the organisms
metabolism alter the oxygen to free radicals. Free radicals are molecules which due to their
structure can react with other molecules resulting in cell damage. This damage is due to
several mechanisms.
This is e.g what happens when human tissue is cut of from blood supply for a time, and the
blood supply is again restored. The damage following the restoration of blood is known as
"ischemia-reperfusion injury". The reopening of the vessels and thereby supplying oxygenated
blood to the deprived tissue can in it self contribute to cell death due to excessive
amounts of free radicals. Antioxidants can neutralize free radicals and thereby minimize
their damage.
The purpose of the investigators methodology study is to make an ischemia-reperfusion model
on healthy volunteers (on the lower limb) to examine the expression of markers that are
expressed in the muscle and the blood when blood supply is cut of to an area and later
restored. The investigators wish to measure the product of the damage caused by free
radicals and the levels of antioxidants.
If the investigators can produce elevation of oxidative and inflammatory markers, this model
can be used to test antioxidative intervention.
n/a
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05327348 -
Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery
|
Phase 3 | |
| Completed |
NCT00184912 -
The Effect of Caffeine on Ischemic Preconditioning
|
N/A | |
| Recruiting |
NCT05585255 -
Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
|
||
| Completed |
NCT05598177 -
Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass
|
Phase 4 | |
| Completed |
NCT04284592 -
Remote Ischemic Postconditioning Increases HIF-1α Plasma Levels and Improves Cardiac Markers After Cardiac Surgery
|
N/A | |
| Withdrawn |
NCT00441714 -
Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise
|
N/A | |
| Completed |
NCT00248040 -
Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation
|
Phase 2 | |
| Recruiting |
NCT06097702 -
A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants
|
Phase 1 | |
| Completed |
NCT01073202 -
Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation
|
N/A | |
| Completed |
NCT00224406 -
Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation
|
Phase 2 | |
| Active, not recruiting |
NCT05246618 -
FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation
|
Phase 1/Phase 2 | |
| Completed |
NCT02118753 -
The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium
|
N/A | |
| Completed |
NCT01739088 -
Pediatric Remote Ischemic Pre-conditioning Prior to Complex Cardiac Surgery
|
N/A | |
| Completed |
NCT01040013 -
Gut Oxygenation and Laparoscopy
|
Phase 2 | |
| Suspended |
NCT00184847 -
Adenosine Receptors Influence Ischemia-Reperfusion Injury
|
N/A | |
| Completed |
NCT01172171 -
The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction
|
Phase 2 | |
| Completed |
NCT00457405 -
Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?
|
Phase 4 | |
| Completed |
NCT00184821 -
Ischemic Injury and Ischemic Preconditioning in Diabetes
|
N/A | |
| Not yet recruiting |
NCT00691613 -
Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model
|
N/A | |
| Completed |
NCT03818126 -
The Del Nido Versus Cold Blood Cardioplegia in Aortic Valve Replacement
|
N/A |